Comparison of dimethyl fumarate and interferon outcomes in an MS cohort

Background To compare the effectiveness of dimethyl fumarate (DMF) with subcutaneous interferon beta-1a (IFNβ-1a) in controlling disease activity in patients with relapsing–remitting Multiple Sclerosis (MS). Methods Clinical and imaging data from patients treated with either IFNβ-1a or DMF for at le...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC neurology Jg. 22; H. 1; S. 1 - 8
Hauptverfasser:	Sattarnezhad, Neda, Healy, Brian C., Baharnoori, Moogeh, Diaz-Cruz, Camilo, Stankiewicz, James, Weiner, Howard L., Chitnis, Tanuja
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 11.07.2022 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	Clinical trials Cohort Comparative analysis Demographics Demography Dimethyl fumarate Disease activity Drug therapy Effectiveness Gadolinium Interferon Medicine Medicine & Public Health Multiple sclerosis Neurochemistry Neurology Neurosurgery Patient outcomes Patients β-Interferon United States Multiple sclerosis Interferon Disease activity Effectiveness Cohort Dimethyl fumarate
ISSN:	1471-2377, 1471-2377
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!